Bulk supplies for pivotal trials in the UK
Global drug supply solutions in the UK: Project Management – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. Warehousing and Distribution – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating—and we can do this, procuring from any region in the world. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch. Discover extra details at warehousing and distribution drug supply.
True commitment to patient safety: ClientPharma is also committed to proactively driving quality — not only because it’s the foundation from which the pharmaceutical industry has been built, but we also understand the significance of the patients’ safety and well-being. It’s our professional duty to service our clients’ needs with the utmost attention and care. CP also has a personal stake in supporting the development of future medicines that will treat and help eliminate life threatening diseases, ensuring we enhance our lives and those of our loved ones.
From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. With our preferred logistics partners, we offer warehousing solutions and specialist logistics to meet your clinical trial requirements. Global pharma warehousing and distribution capabilities: With our own state-of-the-art pharmaceutical warehouses strategically situated in major European and North American distribution hubs, as well as our global network of partner depots, ClientPharma provides you with your clinical trial supplies precisely where and when you need them. With access to our secure pharmaceutical warehousing, you can be confident in the integrity of your supply chain. All of our high-security storage conforms to strict cGDP guidelines. Read additional information on https://www.clientpharma.com/.
Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. ClientPharma (CP) is a specialist global clinical trial supply company providing expertise in the procurement of comparators, rescue medications, adjuvant therapies, standard-of-care, reference drugs, medical devices, ancillaries, and matching placebos. From provision of clinical research samples to bulk supplies for global pivotal trials, the company has built a strong worldwide network to provide strategic commercial drug supply solutions for all stages of clinical programs. Reducing complexity and maximizing value – that’s our mission. CP is headquartered in the United Kingdom with offices and warehousing in the US, Ireland, Belgium, and China.
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.